Skip to content
Recall Observatory FDA recall evidence

Drug product

Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.

D-1445-2014

July 11, 2014

Class III

Product summary

Firm
Sandoz Inc
Event
Event 68860
Status
Terminated
Classification
Class III
Quantity
781,000 extended release tablets
Official record key
drug-enforcement:D-1445-2014

Official wording

Reason: Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.

Code information: Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification